Načítá se...
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
Introduction. The risk of gastrointestinal (GI) bleeding with rivaroxaban has not been studied extensively. The aim of our study was to assess this risk in comparison to warfarin. Methods. We examined the medical records for patients who were started on rivaroxaban or warfarin from April 2011 to Apr...
Uloženo v:
| Vydáno v: | Gastroenterol Res Pract |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736815/ https://ncbi.nlm.nih.gov/pubmed/26880901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9589036 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|